CVLGJul 23, 2024

S-E Pipeline: A Vision Transformer (ViT) based Resilient Classification Pipeline for Medical Imaging Against Adversarial Attacks

arXiv:2407.17587v12 citationsh-index: 5
Originality Incremental advance
AI Analysis

This addresses security risks in automated disease diagnosis for medical imaging, though it is incremental as it builds on existing preprocessing techniques.

The paper tackles the vulnerability of Vision Transformers (ViTs) in medical imaging to adversarial attacks by proposing the S-E Pipeline, which uses segmentation and image enhancement preprocessing to reduce attack impact by 72.22% for ViT-b32 and 86.58% for ViT-l32.

Vision Transformer (ViT) is becoming widely popular in automating accurate disease diagnosis in medical imaging owing to its robust self-attention mechanism. However, ViTs remain vulnerable to adversarial attacks that may thwart the diagnosis process by leading it to intentional misclassification of critical disease. In this paper, we propose a novel image classification pipeline, namely, S-E Pipeline, that performs multiple pre-processing steps that allow ViT to be trained on critical features so as to reduce the impact of input perturbations by adversaries. Our method uses a combination of segmentation and image enhancement techniques such as Contrast Limited Adaptive Histogram Equalization (CLAHE), Unsharp Masking (UM), and High-Frequency Emphasis filtering (HFE) as preprocessing steps to identify critical features that remain intact even after adversarial perturbations. The experimental study demonstrates that our novel pipeline helps in reducing the effect of adversarial attacks by 72.22% for the ViT-b32 model and 86.58% for the ViT-l32 model. Furthermore, we have shown an end-to-end deployment of our proposed method on the NVIDIA Jetson Orin Nano board to demonstrate its practical use case in modern hand-held devices that are usually resource-constrained.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes